STAA Q4 2020 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q4 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$46M+18.3% YoY

Gross Profit

$34M74.6% margin

Operating Income

$4M8.9% margin

Net Income

$3M7.2% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

-2.3%

Cash Flow

Operating Cash Flow

$20M

Free Cash Flow

$17M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$257M

Total Liabilities

$60M

Stockholders' Equity

$197M

Cash & Equivalents

$152M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$46M	$39M	+18.3%
Gross Profit	$34M	$29M	+19.0%
Operating Income	$4M	$2M	+74.1%
Net Income	$3M	$6M	-47.8%

Revenue Segments

Implantable Collamer Lenses

$40M87%

Intraocular Lenses

$4M8%

Other Surgical Products

$2M5%